Wiebe C et al. |
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. |
2017 |
J. Am. Soc. Nephrol. |
pmid:28729289
|
Abongwa C et al. |
Successful treatment of tacrolimus-related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patient. |
2017 |
Pediatr Blood Cancer |
pmid:28598573
|
Wu Z et al. |
FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients. |
2017 |
Eur. J. Clin. Pharmacol. |
pmid:27747372
|
Torres IB et al. |
Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants. |
2017 |
Transpl. Int. |
pmid:28667664
|
Nakagawa K et al. |
Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures. |
2017 |
Am. J. Reprod. Immunol. |
pmid:28466977
|
Harada S et al. |
Complete remission of angiolymphoid hyperplasia with eosinophilia using topical tacrolimus. |
2017 |
Eur J Dermatol |
pmid:28007668
|
Bellon H et al. |
The Effect of Immunosuppression on Airway Integrity. |
2017 |
Transplantation |
pmid:28471870
|
Ferjani H et al. |
Beneficial effects of mycophenolate mofetil on cardiotoxicity induced by tacrolimus in wistar rats. |
2017 |
Exp. Biol. Med. (Maywood) |
pmid:26582055
|
Solari S et al. |
Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28261844
|
Cui W et al. |
Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy. |
2017 |
Braz. J. Med. Biol. Res. |
pmid:28355356
|
Siponen M et al. |
Topical tacrolimus, triamcinolone acetonide, and placebo in oral lichen planus: a pilot randomized controlled trial. |
2017 |
Oral Dis |
pmid:28168769
|
Vanhove T et al. |
Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28168728
|
Gao L et al. |
Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation. |
2017 |
Leuk. Res. |
pmid:28273549
|
Aschauer C et al. |
Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis. |
2017 |
PLoS ONE |
pmid:28060893
|
Dong Y et al. |
Risk Factors, Clinical Features, and Treatment Outcomes of Recurrent Mooren Ulcers in China. |
2017 |
Cornea |
pmid:28060068
|
Kim YK et al. |
New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients. |
2017 |
Drug Des Devel Ther |
pmid:29033547
|
Tamura M et al. |
[A case of anti-PL-7 antibody positive polymyositis with thrombotic microangiopathy]. |
2017 |
Nihon Rinsho Meneki Gakkai Kaishi |
pmid:29367529
|
Dutta D et al. |
Recruitment of calcineurin to the TCR positively regulates T cell activation. |
2017 |
Nat. Immunol. |
pmid:27941787
|
Naicker D et al. |
Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients. |
2017 |
Pediatr. Nephrol. |
pmid:28660366
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|